Tomaralimab (Anti-TLR2 / CD282)

Synonyms: OPN-305

For research use only. Not for use in humans.

Home Biosimilar Antibodies Immunology & Inflammation TLR antibody Tomaralimab (Anti-TLR2 / CD282)

Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.

Tomaralimab (Anti-TLR2 / CD282)

Purity & Quality Control

Batch: A233301 Purity: 99% Protein concentration: 4.731mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective TLR Inhibitors

Name Citation TLR7 TLR8 TLR9 TLR4 TLR2 TLR3 TLR1 Others
Enpatoran Hydrochloride 0
CU-CPT-8m 1
CU-CPT9a 2
MD2-IN-1 3
Cu-CPT22 8
Okanin 0 NF-κB
AMG-9810 0 hTRPV1,rTRPV1
TLR4-IN-C34 6
E6446 4 DNA-TLR9
TLR2-IN-C29 18
MD2-TLR4-IN-1 0 IL-6,TNF-α
IAXO-102 0 NF-κB,MAPK
E6446 dihydrochloride 3
Resatorvid (TAK-242) 61 IL-6,NO,TNF-α
Ginsenoside Rb1 4 IFN-β,TNF-α,NF-κB
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.

Product Details

CAS No. 1449294-76-1
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.